Manager × security

Pacer Advisors, Inc. CVS holdings history

Who else holds this security?

CVS HEALTH CORP · CUSIP 126650100 · CIK 1616667

Some filings reported values in thousands; those figures were scaled ×1000 to dollars.
This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, Pacer Advisors, Inc. reported 95.04K CVS (shares), valued at $9.83M, or 0.03% of its reported non-derivative portfolio. Filed 2026-08-13.

Verify history & sources
Portfolio weight and quantity history
Reported portfolio weight
0.03%
Shares
95.04K
95,039
Reported value
$9.83M
USD

Shares decreased 98.04%; reported value decreased 97.17%, and weight changed -0.97 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 20260.03%95,039SEC filingFiled Aug 13, 2026
Q1 20261.00%4,845,221SEC filingFiled Jun 18, 2026Amended
Q4 20250.03%132,339SEC filingFiled Feb 24, 2026Amended
Q3 20250.03%158,795SEC filingFiled Oct 15, 2025
Q2 20250.02%103,924SEC filingFiled Aug 12, 2025
Q1 20250.01%64,308SEC filingFiled May 6, 2025
Q4 20240.02%194,439SEC filingFiled Jan 22, 2025
Q3 20240.09%633,045SEC filingFiled Nov 12, 2024
Q2 20240.08%617,156SEC filingFiled Aug 13, 2024
Q1 20241.12%6,122,138SEC filingFiled May 10, 2024
Q4 20231.23%5,513,230SEC filingFiled Jan 16, 2024
Q3 20231.31%4,896,445SEC filingFiled Nov 13, 2023

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q3 20231.31%4,896,445$341.87MThe prior quarter is outside the free window. Sign in for the comparison.SEC filing
Filed Nov 13, 2023
Q4 20231.23%5,513,230$435.32MShares increased 12.60%; reported value increased 27.34%, and weight changed -0.08 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Jan 16, 2024
Q1 20241.12%6,122,138$488.30MShares increased 11.04%; reported value increased 12.17%, and weight changed -0.11 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed May 10, 2024
Q2 20240.08%617,156$36.45MShares decreased 89.92%; reported value decreased 92.54%, and weight changed -1.04 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Aug 13, 2024
Q3 20240.09%633,045$39.81MShares increased 2.57%; reported value increased 9.21%, and weight changed +0.01 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Nov 12, 2024
Q4 20240.02%194,439$8.73MShares decreased 69.29%; reported value decreased 78.07%, and weight changed -0.07 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Jan 22, 2025
Q1 20250.01%64,308$4.36MShares decreased 66.93%; reported value decreased 50.08%, and weight changed -0.01 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed May 6, 2025
Q2 20250.02%103,924$7.17MShares increased 61.60%; reported value increased 64.54%, and weight changed +0.01 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Aug 12, 2025
Q3 20250.03%158,795$11.97MShares increased 52.80%; reported value increased 67.00%, and weight changed +0.01 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Oct 15, 2025
Q4 20250.03%132,339$10.50MShares decreased 16.66%; reported value decreased 12.27%, and weight changed +0.00 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Feb 24, 2026
Q1 20261.00%4,845,221$347.98MShares increased 3561.22%; reported value increased 3213.37%, and weight changed +0.97 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Jun 18, 2026
Q2 20260.03%95,039$9.83MShares decreased 98.04%; reported value decreased 97.17%, and weight changed -0.97 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Aug 13, 2026
Pacer Advisors, Inc. · CVS HEALTH CORP

Take these holdings further.

This page includes 12 of 12 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"1616667","quarter":"2026Q2","cusip":"126650100"}

get_institutional_manager_history
{"cik":"1616667","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.